2 research outputs found
Silylated Precision Particles for Controlled Release of Proteins
With
the recent advances in the development of novel protein based therapeutics,
controlled delivery of these biologics is an important area of research.
Herein, we report the synthesis of microparticles from bovine serum
albumin (BSA) as a model protein using Particle Replication in Non-wetting
Templates (PRINT) with specific size and shape. These particles were
functionalized at room temperature using multifunctional chlorosilane
that cross-link the particles to render them to slowly-dissolving
in aqueous media. Mass spectrometric study of the reaction products
of diisopropyldichlorosilane with individual components of the particles
revealed that they are capable of reacting and forming cross-links.
Energy dispersive spectroscopy (EDS) and X-ray photoelectron spectroscopy
(XPS) were also used to confirm the functionalization of the particles.
Cross sectional analysis using focused ion beam (FIB) and EDS proved
that the functionalization occurs throughout the bulk of the particles
and is not just limited to the surface. Circular dichroism data confirmed
that the fraction of BSA molecules released from the particles retains
its secondary structure thereby indicating that the system can be
used for delivering protein based formulations while controlling the
dissolution kinetics
Sensitized Photodecomposition of Organic Bisphosphonates By Singlet Oxygen
During efforts to stabilize metal oxide bound chromophores
for
photoelectrochemical applications, a novel photochemical reaction
has been discovered. In the reaction, the bisphosphonate functional
groups −CÂ(PO<sub>3</sub>H<sub>2</sub>)<sub>2</sub>(OH) in the
metal complex [RuÂ(bpy)<sub>2</sub>(4,4′-(CÂ(OH)Â(PO<sub>3</sub>H<sub>2</sub>)<sub>2</sub>bpy)]<sup>2+</sup> are converted into −COOH
and H<sub>3</sub>PO<sub>4</sub>. The reaction occurs by sensitized
formation of <sup>1</sup>O<sub>2</sub> by the lowest metal-to-ligand
charge transfer excited state(s) of [RuÂ(bpy)<sub>2</sub>(4,4′-(CÂ(PO<sub>3</sub>H<sub>2</sub>)<sub>2</sub>(OH))<sub>2</sub>(bpy))]<sup>2+</sup>* followed by <sup>1</sup>O<sub>2</sub> oxidation of the bisphosphonate
substituent. A related reaction occurs for the bisphosphonate-based
drug, risedronic acid, in the presence of O<sub>2</sub>, light, and
a singlet oxygen sensitizer ([RuÂ(bpy)<sub>3</sub>]<sup>2+</sup> or
Rose Bengal)